Design, synthesis, molecular docking and anticonvulsant evaluation of novel 6-iodo-2-phenyl-3-substituted-quinazolin-4(3H)-ones

Zayed, 2013, Design, synthesis, and biological evaluation studies of novel quinazolinone derivatives as anticonvulsant agents, Med Chem Res, 22, 5823, 10.1007/s00044-013-0569-5 Ajeet Kumar, 2013, Designing of hybrid form of benzothiazole-quinazoline as GABA-A inhibitor with anticonvulsant profile: an in-silico approach, Am J Pharm Sci, 1, 116, 10.12691/ajps-1-6-2 Sahoo, 2013, Green synthesis and evaluation of 3-(aryl)-2-thioxo-2,3-dihydro-quinazolin-4(1H)-ones as anticonvulsant drugs, Int J Pharm Sci Nanotech, 6, 2046 Kumar, 2011, Design, synthesis and potential 6Hz psychomotor seizure test activity of some novel 2-(substituted)-3-{[substituted]amino}quinazolin-4(3H)-one, Eur J Med Chem, 46, 1006, 10.1016/j.ejmech.2011.01.009 Abdel Gawad, 2011, Design, synthesis and anticonvulsant activity of novel quinazolinone analogues, Med Chem Res, 20, 1280, 10.1007/s00044-010-9465-4 Ilangovan, 2010, Design and synthesis of novel quinazolinone derivatives as broad spectrum anticonvulsants and antimicrobial agent, J Pharm Res, 3, 703 Kashaw, 2008, Design, synthesis and potential CNS activity of some novel 1-(4-substituted-phenyl)-3-(4-oxo-2-propyl-4H-quinazolin-3-yl)-urea, ARKIVOC, xiv17, 10.3998/ark.5550190.0009.e03 Nagwa, 2011, Design, synthesis and anticonvulsant activity of novel quinazolinone analogues, Med Chem Res, 20, 1280, 10.1007/s00044-010-9465-4 Jatav, 2008, CNS depressant and anticonvulsant activities of some novel 3-[5-substituted1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones, Eur J Med Chem, 43, 1945, 10.1016/j.ejmech.2007.12.003 Wolfe, 1990, Synthesis and anticonvulsant activity of some new 2-substituted-3-aryl-4(3H)-quinazolinone, J Med Chem, 33, 161, 10.1021/jm00163a027 El-Azab, 2012, Design, synthesis and anticonvulsant evaluation of novel 8-substituted-4(3H)-quinazolines, Med Chem Res, 21, 3785, 10.1007/s00044-011-9914-8 Available: http://en.wikipedia.org/wiki/GABAA_receptor [accessed 15.07.14]. Aziza, 1997, Synthesis and anticovulsant testing of some new 2-phenyl-6-iodo-3-substituted-4-(3H)-quinazolinone derivatives, Az J Pharm Sci, 19, 129 Zappala, 2003, 1-Aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents, Bioorg Med Chem Lett, 13, 4427, 10.1016/j.bmcl.2003.09.032 Bhandari, 2013, Novel 2-pyrazoline derivatives as potential anticonvulsant agents, Med Chem Res, 22, 5290, 10.1007/s00044-013-0530-7 Ibrahim, 2013, Design and synthesis of some novel 2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)-N-(4-(substituted)phenyl)-acetamide derivatives for biological evaluation as anticonvulsant agents, Bull Fac Pharm Cairo Univ, 51, 101, 10.1016/j.bfopcu.2012.11.003 Patel, 2012, A review on synthesis and biological activities of pyrimidine derivatives, Int J Pharm Bio Sci, 2, 170 Guan, 2014, Design, Synthesis and Anticonvulsant Activity Evaluation of 7-Substituted –[1,2,4]-Triazolo[4,3-f]Pyrimidine Derivatives, Med Chem, 8, 1076 Amr, 2005, Synthesis and reactions of some new substituted pyridine and pyrimidine derivatives as analgesic, anticonvulsant and antiparkinsonian agents, Arch Pharm, 338, 433, 10.1002/ardp.200500982 Aytemir, 2004, Synthesis and evaluation of anticonvulsant and antimicrobial activities of 3-hydroxy-6-methyl-2-substituted 4H-pyran-4-one derivatives, Arch Pharm Pharm Med Chem, 337, 281, 10.1002/ardp.200200754 Saravanan, 2012, Prakash RC () Design, synthesis and anticonvulsant activities of novel 1-(substituted/unsubstitutedbenzylidene)-4-(4-(6,8-dibromo-2-(methyl/phenyl)-4-oxo-quinazolin-3(4H)-yl)phenyl) semicarbazide derivatives, Bioorg Med Chem Lett, 22, 3072, 10.1016/j.bmcl.2012.03.068 Wang, 2003, Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives, J Mol Neurosci, 20, 255, 10.1385/JMN:20:3:255 Ugale, 2012, () Quinazolino–benzothiazoles: fused pharmacophores as anticonvulsant agents, Eur J Med Chem, 53, 107, 10.1016/j.ejmech.2012.03.045 Ibrahim, 2015, Design, synthesis, docking, and biological evaluation of some novel 5-chloro-2-substituted sulfanylbenzoxazole derivatives as anticonvulsant agents, Med Chem Res, 24, 99, 10.1007/s00044-014-1111-0 Alafeefy, 2010, Synthesis, analgesic and anti-inflammatory evaluation of some novel quinazoline derivatives, Eur J Med Chem, 45, 4947, 10.1016/j.ejmech.2010.07.067 Vogel, 2008 Dunham, 1957, A note on a simple apparatus for detecting neurological deficit in rats and mice, J Am Pharm Assoc, 46, 208, 10.1002/jps.3030460322 Rogawski, 2006, Point–Counterpoint: do interictal spikes trigger seizures or protect against them?, Epilepsy Curr, 6, 197, 10.1111/j.1535-7511.2006.00144.x Loscher, 1991, The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs, IV. Protective indices, Epilepsy Res, 9, 1, 10.1016/0920-1211(91)90041-D Crivori, 2000, Predicting blood brain barrier permeation from three-dimensional molecular structure, J Med Chem, 11, 2204, 10.1021/jm990968+ Shank, 2000, An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action, Epilepsia, 41, 3, 10.1111/j.1528-1157.2000.tb02163.x Woodbury, 1952, Design and use of a new electroshock seizure apparatus and analysis of factors altering seizure threshold and pattern, Arch Int Pharmacodyn Ther, 92, 97